ALNY - ALNYLAM PHARMACEUTICALS, INC.
IEX Last Trade
241.805
0.055 0.023%
Share volume: 9,065
Last Updated: Thu 26 Dec 2024 08:29:33 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$241.75
0.06
0.02%
Summary score
40%
Profitability
43%
Dept financing
26%
Liquidity
58%
Performance
36%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2020 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
65.19%
Return on assets
-4.01%
Return on sales
-66.71%
Return on invested capital
-129.97%
Total debt ratio
91.73%
Debt ratio change over timeo
-0.55%
Current Ratio
3.91%
Quick Ratio
3.77%
Cash Position Ratio
3.1%
Short-term ratios 30-Jun-2023 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
138.54%
Return on assets
0.65%
Return on sales
0.15%
Return on invested capital
7.66%
Total debt ratio
103.97%
Debt ratio change over timeo
2.72%
Current Ratio
3.1%
Quick Ratio
3.01%
Cash Position Ratio
2.51%
Last quarter ratios 30-Jun-2024
The data are presented for the financials results of the last quarter.
Return on equity
550.67%
Return on assets
1.21%
Return on sales
7.37%
Return on invested capital
7.73%
Total debt ratio
100.08%
Debt ratio change over time
11.95%
Current Ratio
3.01%
Quick Ratio
2.93%
Cash Position Ratio
2.49%
Performance ratios (change over 4 years) 30-Jun-2020 - 30-Jun-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
360.68%
Return on assets
-96.54%
Return on sales
-46.11%
Return on invested capital
-0.23%
Total debt ratio
-55.2%
Debt ratio change over time
-0.55%
Current Ratio
-0.73%
Quick Ratio
-0.72%
Cash Position Ratio
-0.67%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ALNY | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 65.19% | 15.05% | 35.64% | 7.13% |
| Return on assets | -4.01% | 2.88% | 3.13% | 5.53% |
| Return on sales | -66.71% | 29.62% | 32.25% | 40.49% |
| Return on invested capital | -129.97% | 2.57% | 5.37% | 18.48% |
| Profitability | 25% | 41% | 55% | 78% |
| Total debt ratio | 91.73% | 90.48% | 91% | 25.78% |
| Debt ratio change over time | -0.55% | 326.95% | -8.44% | 1.18% |
| Dept financing | 25% | 50% | 25% | 7% |
| Current Ratio | 3.1% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 3.01% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 2.51% | 0.39% | 1.05% | 2.91% |
| Liquididy | 70% | 12% | 28% | 68% |
| Short-term ratios | ALNY | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 138.54% | 13.14% | 10.88% | 4.07% |
| Return on assets | 0.65% | 2.1% | 1.54% | 3.03% |
| Return on sales | 0.15% | 21.74% | 18.43% | 30.26% |
| Return on invested capital | 7.66% | 1.95% | 2.74% | 9.55% |
| Profitability | 51% | 43% | 37% | 76% |
| Total debt ratio | 103.97% | 92.68% | 93.24% | 21.84% |
| Debt ratio change over time | 2.72% | 51.04% | -101.54% | 1.43% |
| Dept financing | 26% | 47% | 22% | 6% |
| Current Ratio | 3.1% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 3.01% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 2.51% | 0.39% | 1.05% | 2.91% |
| Liquididy | 52% | 12% | 27% | 75% |